Moreover, retrospective studies suggest that metformin, a commonly used anti-diabetic drug that is thought to partially act through activation of AMPK, may decrease the risk of developing various types of cancer, including prostate [23-25]. The gene discussed is PRKAA2; the disease is cancer.